Yaohai is trying so hard to get the medicine he makes to people when they are sick. One way in which we do this is by making something known as Antibody-LNP conjugates. That may seem frightening, but the easiest way to put it is that we are combining two different things to make a new type of medicine. This new medicine can battle against the disease in a way that is safer and more manageable for the body. We always work hard at Yaohai to figure out the more good and efficient ways of chemistry our medicine. We found a highly efficient method to synthesize Antibody-LNP conjugates. So how does it work: it starts with taking little particles called lipid nanoparticles (LNP) and we combine them with specific antibodies. They work by targeting and attaching themselves to specific harmful cells in the body, such as cancer cells. Combining them gives us a new type of medicine that can go to the cells where they are needed most.
This is not simple to make. Not in any way. This is a complex process with many steps and we must be certain to perform each step correctly to have the precise meds that are required. For that, we use some special tools to measure the particles very precisely. They need to be of a proper size and shape. We actually have the ability to freeze and thaw these particles with a machine without damaging them. This is a very difficult and laborious work, but it pays off, since we allow patients who are sick to get well much faster. An issue with standard medicine is that it can also harm healthy cells as well as the crappy ones. It can be very painful and uncomfortable for people. But with targeted drug delivery using our Yaohai Lipid Nanoparticle (LNP) in Licensed Vaccine, the healthy cells in the body can be spared from any damages caused. That makes patients far less ill and helps them recuperate rather more quickly from whatever ails them.
We have this special tools, that let us measure the size very carefully and make sure they get mixed nicely. This is vital as it allows the medicine to work well in the body. We also use a machine to siphon off any remaining moisture from within the particles. In this way we are helping to stabilize and strengthen the particles. We do all this to ensure our Yaohai LNP Encapsuled by Microfluid Mixing is the best it can be, so that patients feel better as soon as possible.
We are so passionate about the possibilities that the future has for us at Yaohai, and we eagerly await every new day to explore what ou sprevious medium counterpart left behind. The whole point is to create a medicine that works and make more people feel better! Today medicine has a lot of new technologies and discoveries. Other innovations for the delivery of drugs and novel applications of gene therapy and cell therapy in disease management are some of the exciting developments.
But it can be hard to deliver RNA drugs to the right cells. Every now and then, some of the drugs have trouble getting to the cells needing their support. Antibody-LNP conjugates allow us to deliver these drugs in an escorted manner. Which means they can perform better and assist quicker healing of more cells. We are very excited about this Yaohai Conjugate VLP Vaccines Manufacturing and look forward to contributing even more in the future.
Yaohai Bio-Pharma, a top 10 Antibody-LNP Conjugate Preparation of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.
Yaohai Bio-Pharma is a leading microbiological CDMO. Our focus has been on microbially produced Antibody-LNP Conjugate Preparation and vaccines for human, veterinary and the management of pet health. We have state-of-the-art RD platforms and manufacturing methods which cover the entire procedure starting with microbial strain creation and cell banking, to process and method development to commercial and clinical production and implementation of cutting-edge solutions. Over the years we have gained vast expertise in bio processing using microbial sources. We have successfully delivered over 200 projects across the globe and have assisted our clients with navigating the regulations from the US FDA, EU EMA, Australia TGA, and China NMPA. We are able to react rapidly to market requirements and offer a customized CDMO services due to our expertise and knowledge.
Antibody-LNP Conjugate Preparation has experience in manufacturing biologics that are that are derived from microorganisms. We provide tailored RD as well as manufacturing solutions, while minimising the risk. We have experimented with a variety of techniques, such as recombinant cellular subunits of vaccines (including peptides), growth factors, hormones and the cytokines. We have specialized in multiple microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) and bacteria intracellular soluble and inclusion bodies (yields up to 10g/L). We also have the BSL-2 fermentation platform to develop bacterial vaccines. We are experts in improving processes, increasing product yields, and decreasing production costs. With an effective technology team, we ensure timely and quality project delivery and bring your products to market faster.
Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality management and regulatory issues. We have developed a solid quality management system that conforms to the current GMP standards and regulations globally. Our regulatory team has an in-depth understanding of the world-wide regulatory frameworks. This allows us to accelerate biological launches. We ensure traceable production processes as well as high-quality products and in compliance with the guidelines of the US FDA and EU EMA. Antibody-LNP Conjugate Preparation and China NMPA are also satisfied. Yaohai BioPharma successfully passed an on-site audit conducted by an accredited Qualified Person of the European Union (QP) to review our GMP system and production facility. We have also been through the first certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.